Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of lamivudine-resistant hepatitis B virus strains

Journal of Clinical Microbiology

Volumn 42, Issue 8, 2004, Pages 3809-3812

  Wightman, Fiona ^a   Walters, Tomos ^c   Ayres, Anna ^c   Bowden, Scott ^c   Bartholomeusz, Angeline ^c   Lau, Daryl ^d   Locarnini, Stephen ^c   Lewin, Sharon R ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; PRIMER DNA; VIRUS DNA;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA EXTRACTION; DNA SEQUENCE; HEPATITIS B VIRUS; HUMAN; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN;

BASE SEQUENCE; COMPUTER SYSTEMS; DNA PRIMERS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LONGITUDINAL STUDIES; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE INHIBITORS; VARIATION (GENETICS); VIRAL LOAD;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 3843089550     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.8.3809-3812.2004     Document Type: Article

References (16)

1. Allen, M., M. Deslauriers, C. Andrews, G. Tipples, K. Walters, D. Tyrrell, N. Brown, and L. Condreay. 1998. Identification and characterisation of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27:1670-1677.
2. Angus, P., R. Vaughan, S. Xiong, H. Yang, W. Delaney IV, C. Gibbs, and C. Brosgart. 2003. Resistance to adefovir dipivoxil therapy associated with development of a novel mutation in the HBV polymerase. Gastroenterology 125:292-297.
3. Bartholomeusz, A., R. Schinazi, and S. Locarnini. 1998. Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease. Viral Hepatitis Rev. 4:167-187.
4. Cane, P. A., P. Cook, D. Ratcliffe, D. Mutimer, and D. Pillay. 1999. Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus. Antimicrob. Agents Chemother. 43:1600-1608.
5. Coia, G., A. Ayres, G. G. Lilley, P. J. Hudson, and R. A. Irving. 1997. Use of mutator cells as a means for increasing production levels of a recombinant antibody directed against hepatitis B. Gene 201:203-209.
6. Delaney IV, W., S. Locarnini, and T. Shaw. 2001. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation. Antivir. Chem. Chemother. 12:1-35.
7. Gan, R. B., M. J. Chu, L. P. Shen, S. W. Qian, and Z. P. Li. 1987. The complete nucleotide sequence of the cloned DNA of hepatitis B virus subtype adr in pADR-1. Sci. Sin. B 30:507-521.
8. Gunthard, H. F., S. D. Frost, A. J. Leigh-Brown, C. C. Ignacio, K. Kee, A. S. Perelson, C. A. Spina, D. V. Havlir, M. Hezareh, D. J. Looney, D. D. Richman, and J. K. Wong. 1999. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J. Virol. 73:9404-9412.
9. Kwok, S., D. E. Kellogg, N. McKinney, D. Spasic, L. Goda, C. Levenson, and J. J. Sninsky. 1990. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res. 18:999-1005.
10. Lewin, S., R. Ribeiro, T. Walters, G. Lau, S. Bowden, S. Locarnini, and A. Perelson. 2001. Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology 34:1012-1020.
11. Lewin, S., M. Vesanen, L. Kostrikis, A. Hurley, M. Duran, L. Zhang, D. Ho, and M. Markowitz. 1999. The use of real-time PCR and molecular beacons to detect virus-replication in HIV-1-infected individuals on prolonged effective antiretroviral therapy. J. Virol. 73:6099-6103.
12. Lok, A. S., F. Zoulim, S. Locarnini, A. Mangia, G. Niro, H. Decraemer, G. Maertens, F. Hulstaert, K. De Vreese, and E. Sablon. 2002. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay. J. Clin. Microbiol. 40:3729-3734.
13. Niesters, H., R. De Man, S. Pas, E. Fries, and A. Osterhaus. Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy. J. Med. Microbiol. 51:695-699.
14. Stuyver, L., S. Locarnini, A. Lok, D. Richman, W. Carman, J. Dienstag, and R. Schinazi. 2001. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 33:7751-7757.
15. Stuyver, L., C. Van Geyt, S. De Gendt, G. Van Reybroeck, F. Zoulim, G. Leroux-Roels, and R. Rossau. 2000. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J. Clin. Microbiol. 38:702-707.
16. Whalley, S. A., D. Brown, C. G. Teo, G. M. Dusheiko, and N. A. Saunders. 2001. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler. J. Clin. Microbiol. 39:1456-1459.